ONTTF
Price
$2.09
Change
+$0.11 (+5.56%)
Updated
Jul 10 closing price
Capitalization
1.89B
RLFTF
Price
$2.85
Change
+$0.09 (+3.26%)
Updated
Jul 10 closing price
Capitalization
35.41M
Interact to see
Advertisement

ONTTF vs RLFTF

Header iconONTTF vs RLFTF Comparison
Open Charts ONTTF vs RLFTFBanner chart's image
Oxford Nanopore Technologies
Price$2.09
Change+$0.11 (+5.56%)
Volume$6.61K
Capitalization1.89B
RELIEF THERAPEUTICS HLDG AG
Price$2.85
Change+$0.09 (+3.26%)
Volume$221
Capitalization35.41M
ONTTF vs RLFTF Comparison Chart in %
Loading...
ONTTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONTTF vs. RLFTF commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONTTF is a Buy and RLFTF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ONTTF: $2.08 vs. RLFTF: $2.85)
Brand notoriety: ONTTF and RLFTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONTTF: 91% vs. RLFTF: 4%
Market capitalization -- ONTTF: $1.89B vs. RLFTF: $35.41M
ONTTF [@Biotechnology] is valued at $1.89B. RLFTF’s [@Biotechnology] market capitalization is $35.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONTTF’s FA Score shows that 0 FA rating(s) are green whileRLFTF’s FA Score has 1 green FA rating(s).

  • ONTTF’s FA Score: 0 green, 5 red.
  • RLFTF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ONTTF and RLFTF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONTTF’s TA Score shows that 4 TA indicator(s) are bullish while RLFTF’s TA Score has 3 bullish TA indicator(s).

  • ONTTF’s TA Score: 4 bullish, 3 bearish.
  • RLFTF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ONTTF is a better buy in the short-term than RLFTF.

Price Growth

ONTTF (@Biotechnology) experienced а +6.15% price change this week, while RLFTF (@Biotechnology) price change was +1.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

RLFTF is expected to report earnings on Apr 10, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONTTF($1.89B) has a higher market cap than RLFTF($35.4M). ONTTF YTD gains are higher at: 26.444 vs. RLFTF (-38.778).
ONTTFRLFTFONTTF / RLFTF
Capitalization1.89B35.4M5,350%
EBITDAN/A-48.16M-
Gain YTD26.444-38.778-68%
P/E RatioN/AN/A-
RevenueN/A8.59M-
Total CashN/A10.7M-
Total DebtN/A2.42M-
TECHNICAL ANALYSIS
Technical Analysis
ONTTFRLFTF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
69%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ONTTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEMVX12.94N/A
N/A
Causeway Emerging Markets Investor
LPERX4.61N/A
N/A
ALPS Global Opportunity R
NLCCX33.97N/A
N/A
Voya Large-Cap Growth C
EDIAX11.38N/A
N/A
Eaton Vance Global Income Builder A
OTCHX30.54N/A
N/A
MFS Mid Cap Growth R3

ONTTF and

Correlation & Price change

A.I.dvisor tells us that ONTTF and DNLI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONTTF and DNLI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONTTF
1D Price
Change %
ONTTF100%
+5.05%
DNLI - ONTTF
30%
Poorly correlated
+2.33%
QSI - ONTTF
27%
Poorly correlated
-3.21%
ALEC - ONTTF
26%
Poorly correlated
+4.24%
ADPT - ONTTF
26%
Poorly correlated
+1.26%
TECH - ONTTF
25%
Poorly correlated
+3.46%
More

RLFTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTF has been loosely correlated with RLFTY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTF jumps, then RLFTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTF
1D Price
Change %
RLFTF100%
+3.26%
RLFTY - RLFTF
44%
Loosely correlated
+0.66%
ORKA - RLFTF
30%
Poorly correlated
-1.12%
DRUG - RLFTF
21%
Poorly correlated
-2.45%
PCVX - RLFTF
20%
Poorly correlated
+1.29%
ONTTF - RLFTF
17%
Poorly correlated
+5.05%
More